• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

由C端截短的α-突触核蛋白组装而成的合成细丝。

Synthetic filaments assembled from C-terminally truncated alpha-synuclein.

作者信息

Crowther R A, Jakes R, Spillantini M G, Goedert M

机构信息

Medical Research Council, Laboratory of Molecular Biology, Cambridge, UK.

出版信息

FEBS Lett. 1998 Oct 9;436(3):309-12. doi: 10.1016/s0014-5793(98)01146-6.

DOI:10.1016/s0014-5793(98)01146-6
PMID:9801138
Abstract

Recently two point mutations in the alpha-synuclein gene have been found in familial Parkinson's disease. The characteristic fibrous neuropathological lesions of Parkinson's and other neurodegenerative diseases have been shown to stain strongly with antibodies against alpha-synuclein and extracted filaments have been labelled with anti-alpha-synuclein antibodies. In view of the close involvement of alpha-synuclein filaments with pathology, it was important to establish an in vitro assembly system. We report here that C-terminally truncated recombinant alpha-synuclein readily assembles into filaments resembling those isolated from diseased brain and suggest that truncation by proteolysis may play a role in the pathological process.

摘要

最近,在家族性帕金森病中发现了α-突触核蛋白基因的两个点突变。帕金森病和其他神经退行性疾病的典型纤维状神经病理损伤已被证明能与抗α-突触核蛋白抗体强烈染色,并且提取的细丝已用抗α-突触核蛋白抗体标记。鉴于α-突触核蛋白细丝与病理学密切相关,建立体外组装系统很重要。我们在此报告,C末端截短的重组α-突触核蛋白很容易组装成类似于从患病大脑中分离出的细丝,并表明蛋白水解截短可能在病理过程中起作用。

相似文献

1
Synthetic filaments assembled from C-terminally truncated alpha-synuclein.由C端截短的α-突触核蛋白组装而成的合成细丝。
FEBS Lett. 1998 Oct 9;436(3):309-12. doi: 10.1016/s0014-5793(98)01146-6.
2
Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease.与早发性帕金森病相关的突变α-突触核蛋白加速体外原纤维形成。
Nat Med. 1998 Nov;4(11):1318-20. doi: 10.1038/3311.
3
Fiber diffraction of synthetic alpha-synuclein filaments shows amyloid-like cross-beta conformation.合成α-突触核蛋白细丝的纤维衍射显示出类似淀粉样蛋白的交叉β构象。
Proc Natl Acad Sci U S A. 2000 Apr 25;97(9):4897-902. doi: 10.1073/pnas.97.9.4897.
4
Effect of familial Parkinson's disease point mutations A30P and A53T on the structural properties, aggregation, and fibrillation of human alpha-synuclein.家族性帕金森病点突变A30P和A53T对人α-突触核蛋白结构特性、聚集及纤维化的影响
Biochemistry. 2001 Sep 25;40(38):11604-13. doi: 10.1021/bi010616g.
5
Enhanced vulnerability to oxidative stress by alpha-synuclein mutations and C-terminal truncation.α-突触核蛋白突变和C末端截短增强对氧化应激的易感性。
Neuroscience. 2000;97(2):279-84. doi: 10.1016/s0306-4522(00)00077-4.
6
Effects of the mutations Ala30 to Pro and Ala53 to Thr on the physical and morphological properties of alpha-synuclein protein implicated in Parkinson's disease.丙氨酸30突变为脯氨酸以及丙氨酸53突变为苏氨酸对与帕金森病相关的α-突触核蛋白的物理和形态学特性的影响。
FEBS Lett. 1998 Nov 27;440(1-2):67-70. doi: 10.1016/s0014-5793(98)01419-7.
7
Mutation E46K increases phospholipid binding and assembly into filaments of human alpha-synuclein.E46K突变增加了人α-突触核蛋白与磷脂的结合以及组装成细丝的能力。
FEBS Lett. 2004 Oct 22;576(3):363-8. doi: 10.1016/j.febslet.2004.09.038.
8
Nuclear localization of alpha-synuclein and its interaction with histones.α-突触核蛋白的核定位及其与组蛋白的相互作用。
Biochemistry. 2003 Jul 22;42(28):8465-71. doi: 10.1021/bi0341152.
9
alpha-Synuclein shares physical and functional homology with 14-3-3 proteins.α-突触核蛋白与14-3-3蛋白在结构和功能上具有同源性。
J Neurosci. 1999 Jul 15;19(14):5782-91. doi: 10.1523/JNEUROSCI.19-14-05782.1999.
10
Lipid droplet binding and oligomerization properties of the Parkinson's disease protein alpha-synuclein.帕金森病蛋白α-突触核蛋白的脂滴结合及寡聚化特性
J Biol Chem. 2002 Feb 22;277(8):6344-52. doi: 10.1074/jbc.M108414200. Epub 2001 Dec 14.

引用本文的文献

1
Differential role of C-terminal truncations on alpha-synuclein pathology and Lewy body formation.α-突触核蛋白C末端截短在病理学及路易小体形成中的不同作用
NPJ Parkinsons Dis. 2025 Aug 26;11(1):261. doi: 10.1038/s41531-025-01084-y.
2
Divalent and Trivalent Metallic Ions Differentially Affect Alpha-Synuclein Aggregation.二价和三价金属离子对α-突触核蛋白聚集有不同影响。
ACS Chem Neurosci. 2025 Sep 17;16(18):3497-3512. doi: 10.1021/acschemneuro.5c00160. Epub 2025 Aug 10.
3
Posttranslational Modifications of -Synuclein, Their Therapeutic Potential, and Crosstalk in Health and Neurodegenerative Diseases.
- 突触核蛋白的翻译后修饰、它们的治疗潜力,以及在健康和神经退行性疾病中的相互作用。
Pharmacol Rev. 2024 Oct 16;76(6):1254-1290. doi: 10.1124/pharmrev.123.001111.
4
Interaction between α-Synuclein and Bioactive Lipids: Neurodegeneration, Disease Biomarkers and Emerging Therapies.α-突触核蛋白与生物活性脂质之间的相互作用:神经退行性变、疾病生物标志物及新兴疗法
Metabolites. 2024 Jun 22;14(7):352. doi: 10.3390/metabo14070352.
5
Mutant mice with rod-specific VPS35 deletion exhibit retinal α-synuclein pathology-associated degeneration.杆状细胞特异性 VPS35 缺失的突变小鼠表现出与视网膜α-突触核蛋白病理相关的退行性变。
Nat Commun. 2024 Jul 23;15(1):5970. doi: 10.1038/s41467-024-50189-0.
6
A Potent Sybody Selectively Inhibits α-Synuclein Amyloid Formation by Binding to the P1 Region.一种强效的 Sybody 通过结合 P1 区域选择性地抑制α-突触核蛋白淀粉样形成。
J Med Chem. 2024 Jun 27;67(12):9857-9868. doi: 10.1021/acs.jmedchem.3c02408. Epub 2024 Jun 6.
7
Ultrastructures of α-Synuclein Filaments in Synucleinopathy Brains and Experimental Models.突触核蛋白病大脑及实验模型中α-突触核蛋白细丝的超微结构
J Mov Disord. 2024 Jan;17(1):15-29. doi: 10.14802/jmd.23213. Epub 2023 Nov 22.
8
The C-terminus of α-Synuclein Regulates its Dynamic Cellular Internalization by Neurexin 1β.α-突触核蛋白的 C 端通过神经连接蛋白 1β 调节其细胞内动态内化。
Mol Biol Cell. 2023 Dec 1;34(13):br21. doi: 10.1091/mbc.E22-11-0496. Epub 2023 Sep 20.
9
A Fluorescent Probe as a Lead Compound for a Selective α-Synuclein PET Tracer: Development of a Library of 2-Styrylbenzothiazoles and Biological Evaluation of [F]PFSB and [F]MFSB.一种作为选择性α-突触核蛋白PET示踪剂先导化合物的荧光探针:2-苯乙烯基苯并噻唑文库的开发以及[F]PFSB和[F]MFSB的生物学评价
ACS Omega. 2023 Aug 15;8(34):31450-31467. doi: 10.1021/acsomega.3c04292. eCollection 2023 Aug 29.
10
Alpha synuclein post translational modifications: potential targets for Parkinson's disease therapy?α-突触核蛋白的翻译后修饰:帕金森病治疗的潜在靶点?
Front Mol Neurosci. 2023 May 25;16:1197853. doi: 10.3389/fnmol.2023.1197853. eCollection 2023.